Global Optical Preclinical Imaging Market Report and Forecast 2024-2032

Global Optical Preclinical Imaging Market Outlook

The global optical preclinical imaging market size was valued at USD 640.4 million in 2023, driven by rising technical advancements in optical imaging facilitating smooth drug development across the globe. The market is expected to grow at a CAGR of 5% during the forecast period of 2024-2032, with the values likely to rise from USD 672.4 million in 2024 to USD 992.5 million by 2032.

Optical Preclinical Imaging: Introduction

Preclinical imaging is an essential diagnostic and research tool used in drug development and discovery. Preclinical imaging includes micro-ultrasound, optical imaging, CT, PET, and MRIs, among others. Optical imaging is divided into bioluminescence and fluorescence. It is rapid, easy to perform, and is commonly used for molecular visualizations. It can prove to be highly effective for the pharmaceutical industry as it enables the prior analysis of drugs in pipeline, facilitating faster drug development.

Global Optical Preclinical Imaging Market Analysis

The sudden outbreak of COVID-19 and increasing prevalence of chronic diseases has expediated drug and vaccine development. With the ongoing trend of machine learning and artificial intelligence, the healthcare industry is witnessing the convergence of new technologies into medical ecosystem. This is has led to significant optical preclinical imaging market demand.

Animals are often used as the initial model for testing and determining the effects of a drug. However, collecting the data sets can be difficult, owing to their different sizes and physical positions. To solve this problem, InVivo analytics has developed a fast cloud-based data analysis platform called InVIvoAX. Imaging software like Harmony® and Columbus™ are being used for high content imaging, data storage and analysis.

The optical preclinical imaging market growth can also be accredited to the advent of new imaging technologies. Researchers have introduced imaging mass cytometry to analyze the detection of proteins within tissue sections with the help of heavy metal tagged antibodies. In September 2023, Revvity Inc., unveiled an enhanced imaging portfolio in preclinical research which includes IVIS® Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, crafted to elevate the sensitivity standards in in vivo optical imaging.

To facilitate fast-tracking and rapid evaluation of therapeutic candidates, Revvity's QuantumTM GX3 microCT structural imaging solution has been enabled with increased resolution and speed for both in vivo and ex vivo imaging. Such product launches will add significant growth the optical preclinical imaging market value.

Global Optical Preclinical Imaging Market Segmentation

Market Breakup by Modality

• Bioluminescence/Fluorescence Imaging Systems

• Standalone Fluorescence Imaging Systems

• Optical + X-Ray/ Optical + CT

Market Breakup by Reagent

• Bioluminescent Imaging Reagents

• Fluorescent Imaging Reagent

Market Breakup by Application

• Research and Development

• Drug Discovery

Market Breakup by End User

• Pharma and Biotech Companies

• Research Institutes

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Optical Preclinical Imaging Market Overview

The United States is expected to lead the optical preclinical imaging market share with the implementation of the Inflation Reduction Act of 2022. This act emphasizes the reduction of device and drug prices in the country. This indicates that the traditional research and development methods will take a backseat as the pharma companies keenly adopt machine learning and artificial intelligence technology driven platforms to accelerate drug development. The integration has already been initiated and it is fairly smooth, owing to the presence of a robust healthcare infrastructure.

Europe has been one of the leading regions in the market as it is home to several academic institutions, pioneering research and development in numerous healthcare domains. Asia Pacific is also expected to witness the fastest growth attributed to rising medical infrastructure development. In addition, major healthcare companies have been making hefty investments in the region to leverage the easy availability of both economical and intellectual resources.

Global Optical Preclinical Imaging Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Stryker

• Smith+Nephew

• NuVasive Inc.

• Arthrex Inc. 

• Orthofix US LLC

• Johnson & Johnson Services, Inc.

• Pega Medical Inc.

• WishBone Medical

• Zimmer Biomet

• Medtronic

• Auxein Medical

• Implanet SA

• Merete GmbH

• Mighty Oak Medical

Key Highlights of the Report